Rotigaptide
- Generic Name
- Rotigaptide
- Drug Type
- Small Molecule
- Chemical Formula
- C28H39N7O9
- CAS Number
- 355151-12-1
- Unique Ingredient Identifier
- GFA1W6KO7N
- Background
Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.
Gap Junction Potentiation of Endothelial Function With Rotigaptide
Not Applicable
Completed
- Conditions
- Vascular DiseaseHeart Disease
- Interventions
- Other: Forearm vascular study
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 10
- Registration Number
- NCT00901563
- Locations
- 🇬🇧
Clincial Research Facility, Royal Infirmary of Edinburgh, 51 Little France Cresc, Edinburgh, United Kingdom
Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia
Phase 2
Terminated
- Conditions
- Arrhythmias
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 500
- Registration Number
- NCT00124891
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath